静脈内輸液バッグの市場規模・シェア・成長分析 (容量別、エンドユーザー別、用途別、材料別、地域別)：産業予測 (2025～2032年)

世界の静脈内 (IV) 輸液バッグの市場規模は、2023年に34億米ドルと評価され、2024年の36億4,000万米ドルから2032年には63億米ドルに成長し、予測期間 (2025-2032年) のCAGRは7.1%に達する見通しです。

医療用輸液バッグ市場は、院内感染や交差汚染を軽減するための技術革新や、使い捨て輸液バッグへの人気拡大によって、大きな成長を遂げています。内袋と外側のプラスチックコーティングで設計されたこれらの多用途バッグは、血液サンプル・薬剤・輸液の安全な保管を保証し、滅菌プロセスを強化します。これらのバッグは、補液療法や輸血、電解質バランスの維持において重要な役割を果たしており、これは患者の健康にとって不可欠です。さらに、PVCフリーバッグや非ラテックスバッグの採用が増加していることは、業界がより安全な代替品へとシフトしていることを浮き彫りにしています。医療施設がコスト削減に努めながら感染制御を優先させる中、こうした先進的な輸液バッグの需要は今後数年で大幅に伸びると予想されます。

目次

イントロダクション

• 分析目的
• 市場範囲
• 定義

分析手法

• 情報調達
• 二次・一次データの手法
• 市場規模予測
• 市場の想定と制約

エグゼクティブサマリー

• 市場の概要と展望
• 需給動向の分析
• セグメント別の機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析

市場の主な考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場魅力度指数 (2024年)
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析

世界の静脈内輸液バッグの市場規模・CAGR：容量別 (2025～2032年)

• 市場概要
• 250ml未満
• 250～500ml
• 500ml

世界の静脈内輸液バッグの市場規模・CAGR：エンドユーザー別 (2025～2032年)

• 市場概要
• 病院・診療所
• 外来手術センター
• 在宅医療

世界の静脈内輸液バッグの市場規模・CAGR：用途別 (2025～2032年)

• 市場概要
• 水分補給
• 投薬管理
• 輸血

世界の静脈内輸液バッグの市場規模・CAGR：材料別 (2025～2032年)

• 市場概要
• PVC
• 非PVC

世界の静脈内輸液バッグの市場規模・CAGR (2025～2032年)

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング (2024年)
• 主要企業が採用した戦略
• 市場の近年の動向
• 主要企業の市場シェア (2024年)
• 主要企業のプロファイル
  • 企業概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較 (2022～2024年)

主要企業のプロファイル

• Baxter International Inc. (米国)
• B. Braun Melsungen AG (ドイツ)
• Fresenius Kabi AG (ドイツ)
• ICU Medical, Inc. (米国)
• JW Life Science Corp. (韓国)
• Pfizer Inc. (米国)
• Grifols, S.A. (スペイン)
• Amcor plc (スイス)
• Technoflex (フランス)
• Sippex (ドイツ) (A MEDIPPEX Co.)
• Polycine GmbH (ドイツ)
• Otsuka Pharmaceutical Co., Ltd. (日本)
• Nipro Corporation (日本)
• West Pharmaceutical Services, Inc. (米国)
• Smiths Medical (英国)
• Haemotronic S.p.A. (イタリア)
• MedicoPack A/S (デンマーク)
• Kraton Corporation (米国)
• PolyCine GmbH (ドイツ)
• Fosmo Med (中国)

結論と推奨事項

Global Intravenous IV Fluid Bags Market size was valued at USD 3.4 billion in 2023 and is poised to grow from USD 3.64 billion in 2024 to USD 6.3 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The medical fluid bag market is witnessing significant growth, driven by innovations and a rising preference for disposable IV fluid bags to mitigate hospital-acquired infections and cross-contamination. Designed with an interior pouch and outer plastic coating, these versatile bags ensure the safe storage of blood samples, medications, and fluids, thereby enhancing sterilization processes. They play a critical role in fluid replacement therapy, blood transfusions, and maintaining electrolyte balance, which is vital for patient health. Moreover, the increasing adoption of PVC-free and non-latex bags highlights the industry's shift towards safer alternatives. As healthcare facilities prioritize infection control while striving to reduce costs, the demand for these advanced fluid bags is expected to grow considerably in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intravenous Iv Fluid Bags market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intravenous Iv Fluid Bags Market Segmental Analysis

Global Intravenous IV Fluid Bags Market is segmented by Capacity, End User, Application, Material and region. Based on Capacity, the market is segmented into < 250 ml, 250 to 500 ml and > 500 ml. Based on End User, the market is segmented into Hospitals and Clinics, Ambulatory Surgical Centres and Homecare Settings. Based on Application, the market is segmented into Fluid Replacement, Medication Administration and Blood Transfusion. Based on Material, the market is segmented into PVC and Non-PVC. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intravenous Iv Fluid Bags Market

The global intravenous (IV) fluid bags market is significantly driven by the increasing aging population, which contributes to a rise in various health conditions necessitating advanced treatment methodologies. As individuals age, they often experience a higher prevalence of chronic illnesses that require prompt and efficient medication delivery systems. Intravenous administration is favored over oral methods due to its rapid and precise outcomes, leading to greater patient satisfaction and improved health results. Furthermore, heightened awareness among consumers regarding the benefits of IV fluid administration is anticipated to bolster market growth throughout the forecast period, underscoring the vital role these products play in modern healthcare provision.

Restraints in the Global Intravenous Iv Fluid Bags Market

The Global Intravenous IV Fluid Bags market faces significant restraints due to several pressing concerns. Authorities are increasingly apprehensive about the risk of infections and vein collapse associated with prolonged use of needles, which could adversely affect market growth. Additionally, the potential for nutrient imbalances resulting from suboptimal monitoring of intravenous therapies presents another challenge. Furthermore, alternative solutions such as plastic and glass bottles, as well as infusion pumps, offer competition to traditional IV fluid bags, potentially diminishing demand. Moreover, standard 1-liter IV bags pose risks when used in pediatric care, as children should not be exposed to such large volumes of electrolyte solutions.

Market Trends of the Global Intravenous Iv Fluid Bags Market

The Global Intravenous IV Fluid Bags market is witnessing a robust growth trend driven by the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions, particularly among the aging population. Additionally, an increase in gastrointestinal disorders is propelling demand for IV fluid bags. However, concerns over the environmental impact and health risks associated with PVC-based medical fluid bags may pose challenges to market expansion. Despite these hurdles, the global expansion of healthcare facilities and an increased focus on patient care is significantly enhancing the adoption of intravenous fluid bags, ensuring continual market growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Intravenous IV Fluid Bags Market Size by Capacity & CAGR (2025-2032)

• Market Overview
• < 250 ml
• 250 to 500 ml
• 500 ml

Global Intravenous IV Fluid Bags Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Ambulatory Surgical Centres
• Homecare Settings

Global Intravenous IV Fluid Bags Market Size by Application & CAGR (2025-2032)

• Market Overview
• Fluid Replacement
• Medication Administration
• Blood Transfusion

Global Intravenous IV Fluid Bags Market Size by Material & CAGR (2025-2032)

• Market Overview
• PVC
• Non-PVC

Global Intravenous IV Fluid Bags Market Size & CAGR (2025-2032)

• North America (Capacity, End User, Application, Material)
  • US
  • Canada
• Europe (Capacity, End User, Application, Material)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Capacity, End User, Application, Material)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Capacity, End User, Application, Material)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Capacity, End User, Application, Material)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JW Life Science Corp. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amcor plc (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Technoflex (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sippex (Germany) (A MEDIPPEX Co.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polycine GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemotronic S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedicoPack A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kraton Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PolyCine GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fosmo Med (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations